Ask what ketamine treatment costs in Europe and you are really asking two questions. One is about racemic ketamine infusions, an off-label private-market service where clinics set their own fees. The other is about esketamine nasal spray (Spravato), an approved medicine that in most of continental Europe is paid for by the public system rather than the patient. The two price logics have almost nothing in common, and mixing them up is the fastest way to misjudge your options.
This guide collects every price actually published by the providers in our directory as of July 2026, aggregates them by country, and pairs them with the coverage rules from our country reimbursement guides. Where a clinic does not publish a price, we say so rather than guessing.
Published prices at a glance
The table covers only countries where at least one directory provider publishes prices. You will be quoted in the local currency, so we have left the figures unconverted.
| Country | Single session (published) | Programmes (published) | Public coverage alternative |
|---|---|---|---|
| United Kingdom | £265–595 per infusion | £3,400–6,050 full KAP programmes; ~£3,000/year at an NHS self-funded service | None routine in England and Wales; Spravato covered in Scotland (guide) |
| Germany | €200–300 per infusion | ~€15,000 six-week private day-clinic programme | Spravato via GKV for on-label TRD (guide) |
| Austria | €350 ketamine session; €450 with psychotherapy; esketamine €150–250 | First consultation €180–400 | Inpatient via hospital financing; outpatient case-by-case (guide) |
| Norway | NOK 4,250–7,590 per session | NOK 12,750–47,640 packages | Generic IV ketamine publicly funded since 08/2025 (guide) |
| Poland | 1,200–1,450 PLN maintenance infusion | 9,300–15,660 PLN protocols | Spravato fully funded via NFZ B.147 (guide) |
| Czechia | Not published per session | 17,600–28,600 CZK initial KAP course (contracted insurers); 39,100–49,200 CZK self-pay | Spravato covered since 02/2025; partial KAP coverage (guide) |
| Portugal | €120 initial evaluation | €3,900 KAP programme with insurance; €5,500 without | Spravato in hospital settings since 05/2025 (guide) |
| Spain | €575 infusion with therapeutic accompaniment (one clinic) | Not published | Spravato as hospital medicine since 11/2022 (guide) |
| Switzerland | Not published | Not published | Spravato via OKP at 52 designated centres (guide) |
| Ireland | Not published | Not published | Spravato via HSE since 01/2022 (guide) |
A few of these numbers deserve their footnotes. The £265 figure is not a discount clinic; it is the self-funded ketamine service run inside Oxford Health NHS Foundation Trust, which prices an intravenous infusion and an initial psychiatrist assessment at £265 each and suggests budgeting around £3,000 per year. The £595 London infusion comes with initial consultation packages of £890–1,340 depending on referral route. Poland's 15,660 PLN protocol buys twelve IV infusions plus twelve integration sessions, which works out cheaper per session than most Western European single infusions. And the Czech spread is unusually wide because Prague's Psyon prices by language and therapist count, from 17,600 CZK for a Czech-language initial course with one therapist for contracted-insurer clients up to 72,070 CZK for the self-pay English-language variant with two therapists.
Why most clinics do not publish prices
Of the private ketamine and KAP clinics in our directory, fewer than half put numbers on their websites. The reasons are mostly structural rather than evasive.
Some providers are hospitals. Germany's BKH Bayreuth and Universitätsklinikum Frankfurt, or Switzerland's UPK Basel, treat within hospital billing systems where the cost depends on admission route, insurer category and length of stay. Oberberg Kliniken states openly that it bills a per-day rate plus optional elective services, which cannot be compressed into a single figure. Privatklinik Meiringen is a listed hospital open to basic-insured patients, where inpatient costs are split between canton and insurer under statutory rules, and the clinic files the cost approval request itself.
Others price per treatment plan. The Spanish clinic Las Almas says prices depend on treatment duration, therapy forms and intensity of care. Ireland's Neuromed states there is no single fixed package. Several Swiss practices explain that esketamine can be billed via insurers after a cost approval, while off-label IV ketamine is self-pay with tariffs available on request.
The practical consequence: an unpublished price is not a warning sign in itself, but it does mean your first question to any clinic should be a written quote for the full course, not per session. Our clinic-choice guide covers the other screening questions.
Self-pay and reimbursed routes are different products
The self-pay market and the reimbursed route rarely sell the same thing, which is why comparing them on price alone misleads.
The reimbursed route is almost always esketamine, and almost always narrow. Poland's NFZ programme B.147 funds Spravato fully, drug and monitoring included, at 58 centres in our directory, capped at 34 weeks. Switzerland's OKP reimburses it at 52 designated centres under a strict Limitatio with insurer pre-approval and a 10-month cap. Dutch basic insurance covers drug and treatment sessions at 33 specialised centres. In Germany, GKV covers on-label treatment including office-based practices, though a minority of the 31 German Spravato providers in our directory serve private-insurance and self-pay patients only. Italy's SSN funds it as a hospital medicine (Classe H) at 23 authorised centres. In each case the patient pays standard co-payments at most, and the real costs are time, travel and the observation hours after each dose.
The self-pay market sells something broader and vaguer: racemic ketamine infusions or ketamine-assisted psychotherapy, off-label, with clinic-defined protocols. Prices reflect what is bundled. A bare infusion in Frankfurt at €200–300 and a six-week Berlin day-clinic programme at roughly €15,000 are not the same service at wildly different margins; one is a drug administration, the other includes weeks of structured psychiatric care, and German private insurance often covers the latter in full.
Two countries blur the line usefully. Norway funds generic IV ketamine itself in the public specialist service, so the choice there is between standard co-payments with a referral, or NOK 32,460–47,640 at a private Oslo clinic without one. Czechia is the only country where insurers put money into KAP: Psyon's contracts with seven insurers cover most outpatient psychiatry fully and the ketamine-assisted component partially, roughly halving the initial course price for contracted clients.
If self-pay in Germany still looks tempting for esketamine specifically, note the arithmetic from our German guide: at a list price around €345 per 28 mg device, a four-week induction can reach roughly €8,000 before clinic fees. The covered route exists for a reason.
Questions to ask any clinic about price
Price transparency in this market is earned by asking. Five questions do most of the work.
- What is the full course cost in writing, including assessment, drug, monitoring and integration sessions? Per-session figures hide the total; the UK programmes above range from £3,400 to over £6,000 once everything is counted.
- What happens to fees if screening rules me out? Portugal's Clinic of Change charges €120 for the initial evaluation; ask whether that sum is at risk before you book anywhere.
- Am I eligible for a covered route instead? A clinic selling self-pay ketamine has no obligation to mention that your NFZ, GKV, OKP or SSN route exists. Check the country guide first, or use our eligibility check.
- Which parts can my insurer refund? Austria's Wahlarzt system typically refunds €80–110 per session of a private invoice; Czech coverage depends on which of seven contracted insurers you hold; German private insurers often pay for day-clinic programmes.
- What do maintenance sessions cost after the programme? Relapse-prevention economics matter more than the induction price. Poland's published maintenance infusions at 1,200–1,450 PLN and UK boosters at £1,470–2,940 show how much this varies.
Where the numbers come from
Every figure above is a price published by the provider itself and recorded in our directory, or a coverage rule documented in our country reimbursement guides; nothing is estimated. For the rules behind the coverage column, start with the Europe-wide reimbursement map and the country guides linked in the table. Prices change and clinics reprice; if you find a published figure that differs from ours, we correct quickly.
Sources
- Oxford Health NHS FT: ketamine service pricing
- The Burlington Clinic: ketamine therapy cost in London
- Eulas Clinics: ketamine therapy pricing
- NICE TA854: Esketamine for treatment-resistant depression
- Thieme: esketamine list price and induction cost in Germany
- BAG — Spravato Limitatio and designated-center list (10/2025)
- Nye Metoder: Ketamin — ID2022_018, Beslutningsforum decision of 25 August 2025
- Psyon — psychedelic clinic, Prague: services, insurers and admission criteria
- The Clinic of Change — Lisbon: programmes and published prices
- Reimbursement Pathways for Psychedelic Therapies in Europe — Magnetar Access × Blossom (2025)
This guide is for general information only and is not medical advice, a diagnosis, or a recommendation of any treatment. Prices and reimbursement rules change; always confirm current fees in writing with the provider and coverage with your insurer. If you are in crisis, contact your local emergency number or a crisis line immediately.
This guide awaits review by a licensed medical professional.